Literature DB >> 10100019

Airway epithelial damage and release of inflammatory mediators in human lung parenchyma after sulfur mustard exposure.

J H Calvet1, J P Gascard, S Delamanche, C Brink.   

Abstract

This study was performed to evaluate the morphological effects of sulfur mustard on human lung parenchyma in vitro and to measure the metabolites of arachidonic acid which are released during acute exposure to the alkylating agent. Histological analysis of the tissue following exposure to sulfur mustard for a period of 45 min at 10 mM revealed the presence of paranuclear vacuoles in the epithelium, specifically, in the ciliated cells. The release of metabolites of arachidonic acid were determined in the bath fluids by an enzymo-immunoassay. The basal release of prostaglandin E2 (PGE2: 1.36 +/- 0.33 ng/g tissue) and 6-keto prostaglandin F1 alpha (6-keto PGF1 alpha: 8.83 +/- 1.17 ng/g tissue) were not modified during tissue exposure to sulfur mustard (45 min, 0.1 mM). In addition, the basal release of cysteinyl-leukotriene E4 (LTE4: 1.55 +/- 0.44 ng/g tissue) was also not altered by challenge of the tissues with sulfur mustard. In contrast, when the human lung parenchyma was stimulated with anti human IgE (anti-IgE) only the basal release of the metabolite of the 5-lipoxygenase pathway was significantly increased (LTE4: 6.84 +/- 1.57 ng/g tissue). These data suggest that sulfur mustard may produce morphological alterations in epithelial cells and at the time point studied (45 min exposure), this effect is not associated with a release of arachidonic acid metabolites. However, the increased release of LTE4 by anti-IgE suggests that the target cells for sulfur mustard and anti-IgE in the human lung may be different.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100019     DOI: 10.1177/096032719901800203

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  5 in total

1.  Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas.

Authors:  Ali Gholamrezanezhad; Mohsen Saghari; Arsalan Vakili; Sahar Mirpour; Mohammad Hossein Farahani
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

2.  Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard.

Authors:  Vasanthi R Sunil; Kinal J Patel; Jianliang Shen; David Reimer; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-29       Impact factor: 4.219

Review 3.  Mustard vesicant-induced lung injury: Advances in therapy.

Authors:  Barry Weinberger; Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-19       Impact factor: 4.219

4.  Detection and monitoring of early airway injury effects of half-mustard (2-chloroethylethylsulfide) exposure using high-resolution optical coherence tomography.

Authors:  Kelly A Kreuter; Sari B Mahon; David S Mukai; Jianping Su; Woong-Gyu Jung; Navneet Narula; Shuguang Guo; Nicole Wakida; Chris Raub; Michael W Berns; Steven C George; Zhongping Chen; Matthew Brenner
Journal:  J Biomed Opt       Date:  2009 Jul-Aug       Impact factor: 3.170

5.  A case control study of cardiovascular health in chemical war disabled Iranian victims.

Authors:  Atoosheh Rohani; Vahid Akbari; Fatemeh Tabesh Moghadam
Journal:  Indian J Crit Care Med       Date:  2010-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.